Ja. Eaden et al., How gastroenterologists screen for colonic cancer in ulcerative colitis: an analysis of performance, GASTROIN EN, 51(2), 2000, pp. 123-128
Background: The aim of this study was to assess the colorectal cancer surve
illance practices of British gastroenterologists for patients with ulcerati
ve colitis,
Methods: A questionnaire that investigated aspects of surveillance in patie
nts with ulcerative colitis was mailed to all consultant gastroenterologist
s in the U.K. (n = 413).
Results: Three hundred forty-one questionnaires were returned (response rat
e 83%). Ninety-four percent of consultants practice cancer surveillance in
ulcerative colitis, with 35% maintaining a registry of patients in surveill
ance programs, All gastroenterologists perform surveillance in patients wit
h pancolitis, 24% in those with left-sided colitis and 2% in patients with
proctitis, The mean duration of disease before surveillance is commenced is
9.2 years for pancolitis and 12.4 years for left-sided colitis (p < 0.0001
), Only 4% of gastroenterologists routinely offer patients with disease of
more than 10 years' duration a prophylactic colectomy, Colonoscopies are co
nducted by an accredited gastroenterologist in 65% of cases and biopsies ar
e reviewed by specialists in gastrointestinal pathology in 45%, When histol
ogy reveals low-grade dysplasia only 4% advise colectomy and when high-grad
e dysplasia is found 53% recommend colectomy. Sixteen percent of gastroente
rologists were unaware of the significance of a dysplasia associated lesion
or mass.
Conclusion: The majority of gastroenterologists practice surveillance on a
disorganized basis. There is inconsistency in the management of patients wi
th dysplasia and education of gastroenterologists is needed.